colestipol has been researched along with Coronary Artery Disease in 16 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 3 (18.75) | 18.7374 |
1990's | 11 (68.75) | 18.2507 |
2000's | 2 (12.50) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Azen, SP; LaBree, L; Lapuerta, P | 1 |
Azen, SP; Cashin-Hemphill, L; Hodis, HN; Johnson, R; LaBree, L; Mack, WJ; Sevanian, A | 1 |
Davies, G; Kitano, Y; Maher, VM; Matthews, S; Mir, A; Neuwirth, C; Prescott, RJ; Rees, A; Shortt, MB; Thompson, GR | 1 |
Azen, SP; Blankenhorn, DH; Cashin-Hemphill, L; Hodis, HN; LaBree, L; Mack, WJ; Selzer, RH; Shircore, AM | 1 |
Brown, BG; Brunzell, JD; Hokanson, JE; Zambon, A | 1 |
Hodis, HN; Mack, WJ; Selzer, RH; Xiang, M | 1 |
Hodis, HN; LaBree, L; Liu, C; Mack, WJ; Selzer, RH | 1 |
Azen, SP; Blankenhorn, DH; Crawford, DW; Lee, PL; Mack, WJ; Pogoda, J; Selzer, RH; Shircore, AM | 1 |
Azen, SP; Blankenhorn, DH; Lee, PL; Mack, WJ; Pogoda, JM; Selzer, RH; Shircore, AM | 1 |
Brown, BG | 1 |
Diehl, JC; Havel, RJ; Kane, JP; Malloy, MJ; Phillips, NR; Ports, TA | 1 |
Azen, SP; Blankenhorn, DH; Cashin-Hemphill, L; Mack, WJ; Pogoda, JM; Sanmarco, ME | 1 |
Alaupovic, P; Azen, SP; Blankenhorn, DH; Chin, HP; Wickham, E | 1 |
Dereviacki, BE; Forti, N; Giannini, SD | 1 |
Azen, SP; Blankenhorn, DH; Cashin-Hemphill, L; Johnson, RL; Nessim, SA; Sanmarco, ME | 1 |
1 review(s) available for colestipol and Coronary Artery Disease
Article | Year |
---|---|
[The value of chemotherapeutic intervention on primary hyperlipidemias in the prevention of coronary arteriosclerosis].
Topics: Adult; Cholesterol; Clinical Trials as Topic; Colestipol; Coronary Artery Disease; Humans; Hyperlipidemias; Hypolipidemic Agents; Lipoproteins, LDL; Male; Middle Aged; Probucol | 1988 |
13 trial(s) available for colestipol and Coronary Artery Disease
Article | Year |
---|---|
Serial coronary angiographic evidence that antioxidant vitamin intake reduces progression of coronary artery atherosclerosis.
Topics: Adult; Analysis of Variance; Antioxidants; Ascorbic Acid; Colestipol; Coronary Angiography; Coronary Artery Bypass; Coronary Artery Disease; Diet, Atherogenic; Food, Fortified; Humans; Male; Middle Aged; Randomized Controlled Trials as Topic; Vitamin E | 1995 |
Familial Hypercholesterolaemia Regression Study: a randomised trial of low-density-lipoprotein apheresis.
Topics: Adult; Blood Component Removal; Cholestyramine Resin; Colestipol; Coronary Angiography; Coronary Artery Disease; Data Interpretation, Statistical; Humans; Hyperlipoproteinemia Type II; Hypolipidemic Agents; Lipids; Lipoprotein(a); Lipoproteins, LDL; Lovastatin; Middle Aged; Odds Ratio; Simvastatin | 1995 |
Progression of coronary artery disease predicts clinical coronary events. Long-term follow-up from the Cholesterol Lowering Atherosclerosis Study.
Topics: Adult; Colestipol; Coronary Angiography; Coronary Artery Disease; Diet, Fat-Restricted; Follow-Up Studies; Humans; Hypolipidemic Agents; Male; Middle Aged; Niacin; Predictive Value of Tests | 1996 |
Evidence for a new pathophysiological mechanism for coronary artery disease regression: hepatic lipase-mediated changes in LDL density.
Topics: Aged; Anticholesteremic Agents; Apolipoproteins B; Centrifugation, Density Gradient; Chemical Phenomena; Chemistry, Physical; Cholesterol, LDL; Colestipol; Combined Modality Therapy; Coronary Artery Disease; Drug Therapy, Combination; Humans; Hypolipidemic Agents; Lipase; Lipids; Lipolysis; Lipoproteins; Liver; Lovastatin; Male; Middle Aged; Niacin | 1999 |
Serial quantitative coronary angiography and coronary events.
Topics: Adult; Cholesterol, LDL; Colestipol; Collateral Circulation; Coronary Angiography; Coronary Artery Disease; Coronary Vessels; Death, Sudden, Cardiac; Disease Progression; Double-Blind Method; Drug Therapy, Combination; Electrocardiography; Humans; Hypolipidemic Agents; Male; Middle Aged; Myocardial Infarction; Niacin; Prognosis; Proportional Hazards Models | 2000 |
Correlations between measures of atherosclerosis change using carotid ultrasonography and coronary angiography.
Topics: Adult; Carotid Artery, Common; Carotid Stenosis; Colestipol; Coronary Angiography; Coronary Artery Disease; Disease Progression; Double-Blind Method; Drug Therapy, Combination; Humans; Hypercholesterolemia; Hypolipidemic Agents; Lipids; Male; Middle Aged; Niacin; Observer Variation; Prognosis; Reproducibility of Results; Tunica Intima; Ultrasonography; Video Recording | 2000 |
Comparison of computer- and human-derived coronary angiographic end-point measures for controlled therapy trials.
Topics: Adult; Colestipol; Combined Modality Therapy; Computers; Coronary Angiography; Coronary Artery Disease; Humans; Male; Middle Aged; Niacin | 1992 |
Effect of lovastatin or niacin combined with colestipol and regression of coronary atherosclerosis.
Topics: Apolipoprotein A-I; Apolipoproteins B; Cholesterol, HDL; Cholesterol, LDL; Colestipol; Coronary Angiography; Coronary Artery Disease; Drug Therapy, Combination; Humans; Lovastatin; Male; Middle Aged; Niacin | 1992 |
Regression of coronary atherosclerosis during treatment of familial hypercholesterolemia with combined drug regimens.
Topics: Adult; Aged; Cholesterol, HDL; Cholesterol, LDL; Colestipol; Coronary Artery Disease; Drug Therapy, Combination; Female; Humans; Hyperlipoproteinemia Type II; Lovastatin; Male; Middle Aged; Niacin; Radiographic Image Interpretation, Computer-Assisted; Triglycerides | 1990 |
Beneficial effects of colestipol-niacin on coronary atherosclerosis. A 4-year follow-up.
Topics: Adult; Apolipoproteins; Cholesterol; Colestipol; Coronary Artery Disease; Drug Therapy, Combination; Follow-Up Studies; Humans; Hypercholesterolemia; Lipids; Male; Middle Aged; Niacin; Radiography | 1990 |
Prediction of angiographic change in native human coronary arteries and aortocoronary bypass grafts. Lipid and nonlipid factors.
Topics: Apolipoprotein C-III; Apolipoproteins; Apolipoproteins C; Colestipol; Coronary Angiography; Coronary Artery Bypass; Coronary Artery Disease; Humans; Lipids; Male; Middle Aged; Multivariate Analysis; Niacin; Randomized Controlled Trials as Topic; Recurrence | 1990 |
[The value of chemotherapeutic intervention on primary hyperlipidemias in the prevention of coronary arteriosclerosis].
Topics: Adult; Cholesterol; Clinical Trials as Topic; Colestipol; Coronary Artery Disease; Humans; Hyperlipidemias; Hypolipidemic Agents; Lipoproteins, LDL; Male; Middle Aged; Probucol | 1988 |
Beneficial effects of combined colestipol-niacin therapy on coronary atherosclerosis and coronary venous bypass grafts.
Topics: Adult; Clinical Trials as Topic; Colestipol; Coronary Artery Bypass; Coronary Artery Disease; Drug Therapy, Combination; Graft Occlusion, Vascular; Humans; Lipids; Male; Middle Aged; Niacin; Polyamines; Radiography; Random Allocation | 1987 |
3 other study(ies) available for colestipol and Coronary Artery Disease
Article | Year |
---|---|
Use of neural networks in predicting the risk of coronary artery disease.
Topics: Adult; Cholesterol; Colestipol; Coronary Artery Disease; Coronary Disease; Diet, Fat-Restricted; Follow-Up Studies; Forecasting; Humans; Lipids; Lipoproteins; Longitudinal Studies; Male; Middle Aged; Neural Networks, Computer; Niacin; Placebos; Randomized Controlled Trials as Topic; Regression Analysis; Reproducibility of Results; Risk Factors | 1995 |
Evaluation of colestipol/niacin therapy with computer-derived coronary end point measures. A comparison of different measures of treatment effect.
Topics: Adult; Colestipol; Coronary Angiography; Coronary Artery Bypass; Coronary Artery Disease; Coronary Vessels; Drug Therapy, Combination; Humans; Image Processing, Computer-Assisted; Male; Middle Aged; Niacin; Randomized Controlled Trials as Topic; Treatment Outcome | 1992 |
Colestipol-niacin therapy and coronary atherosclerosis.
Topics: Adult; Colestipol; Coronary Artery Disease; Humans; Male; Middle Aged; Niacin; Polyamines; Research Design | 1987 |